Answers are grounded in this paper and cite their sources.
Rare transitions are central in science, yet their mechanisms are obscured by the high dimensionality of complex dynamics, a challenge particularly pronounced in biomolecules where rare conformational transitions underlie functional processes. A transition-conditioned dynamical fingerprint is introduced for a rare \(A {--} B\) event, in which the transition-relevant subset is targeted rather than a global decomposition and the problem is treated dynamically. Within a selected transition corridor, barrier-crossing motion is extracted and microscopic players are ranked through a corridor-conditioned informativeness measure, after which the highest-ranked players are subjected to intervention tests of their transition leverage using the REST2 scaling scheme, metadynamics, and targeted mutation. Across three benchmark proteins, targeting these players facilitates basin-to-basin transitions while maintaining high fidelity to the prescribed transition corridor, providing handles for mechanistic analysis, enhanced sampling, control, and design.
No takes yet. Share an insight, caveat, or question.
Sharifian et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: